Liu David Y Insider Trades

Insider Trading History

Track insider trading activity for Liu David Y. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief R&d Strategy Officer
Holding Value $19.9M 167,590 shares
Last Trade
Nov 16, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$805k 100,479 shares
$8.01
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief R&d Strategy Officer
Holding Value $0 0 shares
Last Trade
Nov 16, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$283k 35,331 shares
$8.01
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $7.92M 66,538 shares
Last Trade
Feb 28, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$51.4k 2,119 shares
$24.28
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $7.14M 60,000 shares
Last Trade
Feb 15, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.72M 60,000 shares
$28.73
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $8.17M 68,657 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 10,000 shares
$28.73
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $8.69M 73,033 shares
Last Trade
Aug 17, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$483k 10,000 shares
$48.28
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $6.93M 58,254 shares
Last Trade
Aug 17, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$703k 14,779 shares
$47.56
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $1.64M 13,767 shares
Last Trade
Aug 17, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$483k 10,000 shares
$48.28
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $7.73M 65,000 shares
Last Trade
Feb 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.53M 65,000 shares
$23.57
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $8.33M 70,000 shares
Last Trade
Feb 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$546k 70,000 shares
$7.80
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $5.92M 49,802 shares
Last Trade
Aug 06, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$30k 3,395 shares
$8.85
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $6.09M 51,197 shares
Last Trade
Mar 01, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.5k 810 shares
$8.03
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $10.7M 90,000 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$722k 90,000 shares
$8.02
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $4.4M 37,007 shares
Last Trade
Feb 06, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.6k 3,821 shares
$7.74
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $4.86M 40,828 shares
Last Trade
Aug 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 17,200 shares
$8.58
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $4.2M 35,331 shares
Last Trade
Mar 12, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.3k 3,500 shares
$20.94
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $1.79M 15,028 shares
Last Trade
Mar 12, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$74.5k 3,500 shares
$21.29
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $2.2M 18,528 shares
Last Trade
Mar 12, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.3k 3,500 shares
$20.94
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $1.69M 14,197 shares
Last Trade
Mar 02, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.3k 875 shares
$20.86
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Chief Scientific Officer
Holding Value $1.58M 13,322 shares
Last Trade
Mar 02, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.5k 875 shares
$20.00
$118.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up